These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1063 related items for PubMed ID: 25552038

  • 1. [Ergoferon liquid dosage form--efficacious and safe treatment for childhood acute respiratory infections. Interim outcomes of a multi-center, randomized, double-blind, placebo-controlled clinical trial].
    Geppe NA, Kondiurina EG, Galustian AN, Pak TE, Bal'tserovich NB, Zhiglinskaia OV, Kamaev AV, Lazareva SG, Laléko SL, Mel'nikova IM, Perminova OA, Sabitov AU.
    Antibiot Khimioter; 2014; 59(5-6):6-14. PubMed ID: 25552038
    [Abstract] [Full Text] [Related]

  • 2. [Ergoferon and oseltamivir in treatment of influenza: results of multicentre randomized comparative clinical trial].
    Aver'ianov AV, Babkin AP, Bart BIa, Volchetskiĭ AL, Minina ES, Kozyrev OA, Kostinov MP, Petrov DV, Sel'kova EP, Putilovskiĭ MA, Nechaev VB, Epshteĭn OI, Andrianova EN.
    Antibiot Khimioter; 2012; 57(7-8):23-30. PubMed ID: 23350191
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of Ergoferon versus oseltamivir in adult outpatients with seasonal influenza virus infection: a multicenter, open-label, randomized trial.
    Rafalsky V, Averyanov A, Bart B, Minina E, Putilovskiy M, Andrianova E, Epstein O.
    Int J Infect Dis; 2016 Oct; 51():47-55. PubMed ID: 27616034
    [Abstract] [Full Text] [Related]

  • 7. Evaluating Changes in The Clinical Presentation of Acute Obstructive Bronchitis in Preschool Children Using Antiviral Therapy.
    Kondyurina EG, Tyuleneva IO, Burtseva EI, Trushakova SV, Mukasheva EA, Vinogradova AA, Elkina TN, Zelenskaya VV.
    Antibiot Khimioter; 2016 Oct; 61(9-10):33-43. PubMed ID: 29539249
    [Abstract] [Full Text] [Related]

  • 8. Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR).
    Pshenichnaya NY, Bulgakova VA, Lvov NI, Poromov AA, Selkova EP, Grekova AI, Shestakova IV, Maleev VV, Leneva IA.
    Ter Arkh; 2019 Mar 30; 91(3):56-63. PubMed ID: 31094461
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C, Man CY, Henderson FW, McElhaney JE, Hampel FC, Bettis R, Kudule L, Harris J, Yates P, Tisdale M, Webster A.
    Clin Ther; 2007 Aug 30; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.
    Fry AM, Goswami D, Nahar K, Sharmin AT, Rahman M, Gubareva L, Azim T, Bresee J, Luby SP, Brooks WA.
    Lancet Infect Dis; 2014 Feb 30; 14(2):109-18. PubMed ID: 24268590
    [Abstract] [Full Text] [Related]

  • 13. A controlled multicenter pediatric study in the treatment of acute respiratory tract diseases with the aid of a new specific compound, erdosteine (IPSE, Italian Pediatric Study Erdosteine).
    Titti G, Lizzio A, Termini C, Negri P, Fazzio S, Mancini C.
    Int J Clin Pharmacol Ther; 2000 Aug 30; 38(8):402-7. PubMed ID: 10984014
    [Abstract] [Full Text] [Related]

  • 14. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr 30; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections.
    LaForce C, Gentile DA, Skoner DP.
    Postgrad Med; 2008 Jul 30; 120(2):53-9. PubMed ID: 18654069
    [Abstract] [Full Text] [Related]

  • 16. [Non-specific prevention of COVID-19 during vaccination against a new coronavirus infection: results of a multicenter, double-blind, placebo-controlled, randomized clinical trial].
    Avdeeva MG, Belousova ON, Orlova EA, Khamitov RF, Shvarts YG, Kravchenko IE.
    Ter Arkh; 2022 Dec 26; 94(11):1268-1277. PubMed ID: 37167165
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.
    Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, Singh S, Kinnersley N, Ward P, Mills RG.
    JAMA; 2000 Feb 23; 283(8):1016-24. PubMed ID: 10697061
    [Abstract] [Full Text] [Related]

  • 18. [Ergoferon and improvement of etiopathogenetic therapy of influenza and acute respiratore viral infection in adults].
    Verevshchikov VK, Borzunov VM, Shemiakina EK.
    Antibiot Khimioter; 2011 Feb 23; 56(9-10):23-6. PubMed ID: 22586900
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
    Matthys H, de Mey C, Carls C, Ryś A, Geib A, Wittig T.
    Arzneimittelforschung; 2000 Aug 23; 50(8):700-11. PubMed ID: 10994153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.